PRP therapy and cell-based products are being studied as biologic approaches for selected wrist and hand conditions. Researchers are evaluating different products, preparation methods, injection techniques, and patient groups.
What Researchers Are Studying
- Influence inflammation and cellular signaling in injured or painful tissue
- Be delivered safely and feasibly for selected conditions
- Improve pain, grip strength, mobility, function, or other patient-reported outcomes
- Be further evaluated alongside therapy, corticosteroid injection, or other established treatments
PRP, cell-based products, and exosome products are distinct approaches. Research results can vary by diagnosis, product, treatment protocol, injection technique, rehabilitation plan, and outcome measures.
Note: PRP, stem cell, and exosome therapies for wrist and hand conditions are investigational and are not FDA-approved for these uses. Research findings do not guarantee individual results.
How Regenerative Medicine for Wrist and Hand Conditions Is Being Studied
Researchers are studying biologic approaches for hand osteoarthritis, wrist tendinopathy, carpal tunnel syndrome, thumb-base osteoarthritis, and wrist ligament injury. Studies assess pain, function, grip strength, imaging findings, nerve measures, and safety. This work is helping identify the products, delivery methods, and patient groups that warrant continued clinical study. Regenerative treatment for wrist and hand pain remains investigational.